Yahoo Web Search

Search results

1. www.mskcc.org › cancer-care › doctorsKenneth H. Yu, MD - MSK Gastrointestinal Oncologist

   www.mskcc.org › cancer-care › doctors

   • Cached

   Hewitt MR, Yu KH. Treatment update for metastatic pancreatic cancer. Community Oncology. 2006; 3(7) :428-30 . Yu KH, Barry CG, Austin D, Busch CM, Sangar V, Rustgi AK, Blair IA. Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery. J Proteome Res. 2009; 8(3 ...

2. www.mskcc.org › cancer-care › clinical-trialsA Phase I Study of ONC-392 Immunotherapy in People with ...

   www.mskcc.org › cancer-care › clinical-trials

   • Cached

   For more information and to ask about eligibility for this study, please contact the office of Dr. Kenneth Yu at 646-888-4188. Protocol. 22-034. Phase.

3. scholar.google.com › citations‪Kenneth Yu‬ - ‪Google Scholar‬

   scholar.google.com › citations

   • Cached

   ‪Memorial Sloan Kettering Cancer Center‬ - ‪‪Cited by 11,901‬‬ - ‪Pancreatic cancer‬

4. www.researchgate.net › Kenneth-H-Yu-38525611Kenneth H. Yu's research works | Memorial Sloan Kettering ...

   www.researchgate.net › Kenneth-H-Yu-38525611

   Kenneth H. Yu's 170 research works with 9,533 citations and 7,580 reads, including: A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and ...

5. Images

   • 
   • 
   • 
   • 
   • 

   View all

6. www.healthgrades.com › physician › dr-kenneth-yu-2khhgDr. Kenneth Yu, MD - Medical Oncology Specialist in New York ...

   www.healthgrades.com › physician › dr-kenneth-yu-2khhg

   • Cached

   Dr. Kenneth Yu, MD is a medical oncology specialist in New York, NY and has over 24 years of experience in the medical field. He graduated from Johns Hopkins School of Medicine in 1999. He is affiliated with medical facilities Hospital for Special Surgery and Memorial Sloan Kettering Cancer Center.

7. www.mskcc.org › cancer-care › clinical-trialsA Study Comparing Two Standard Chemotherapy Treatments for ...

   www.mskcc.org › cancer-care › clinical-trials

   • Cached

   People with metastatic pancreatic ductal adenocarcinoma are usually treated with one of two standard chemotherapy treatments (regimens): Modified FOLFIRINOX (mFFX), which includes folinic acid (leucovorin), 5-fluorouracil, irinotecan, and oxaliplatin Gemcitabine combined with Abraxane (GA). Abraxane is also called nab-paclitaxel.